A Saskatoon man hopes the antibodies in his blood may help others who contracted the novel coronavirus, especially considering what COVID-19 did to his family.
Andrew Elchuk is the first person in Saskatchewan to enter the CONCOR-1 trial, which aims to assess whether plasma from recovered COVID-19 patients can be given to infected patients as a treatment for the disease.
In early March, he visited Germany and Switzerland with his wife, mother and father. When they heard the Canadian government call its citizens home, they travelled back and went into self-isolation.
A few days in, coronavirus symptoms started to surface in all four travellers. “There was a general sense of being really tired, some chills … loss of appetite,” Andrew said.